ADC Therapeutics SA Inventory Write-down
Financial Statements › Expense Statement › Operating Expenses
us-gaap:InventoryWriteDown · last filed 2026-08-13
- ADC Therapeutics SA inventory write-down for the quarter ending 2026-06-30 was $171.00K, a 56.15% decline year-over-year.
- ADC Therapeutics SA inventory write-down for the quarter ending 2026-03-31 was $1.47M, a 18.22% increase year-over-year.
- ADC Therapeutics SA inventory write-down for the quarter ending 2025-12-31 was $411.00K, a 14.73% decline year-over-year.
- ADC Therapeutics SA inventory write-down for the quarter ending 2025-09-30 was $237.00K.
- ADC Therapeutics SA inventory write-down for fiscal 2025 was $2.28M, a 50.46% increase from fiscal 2024.
- ADC Therapeutics SA inventory write-down for fiscal 2024 was $1.52M, a 5.60% decline from fiscal 2023.
- ADC Therapeutics SA inventory write-down for fiscal 2023 was $1.61M, a 25.73% decline from fiscal 2022.
- ADC Therapeutics SA inventory write-down for fiscal 2022 was $2.17M.
| Period end | Inventory Write-down 3 month | Inventory Write-down 6 month | Inventory Write-down 9 month | Inventory Write-down 12 month |
|---|---|---|---|---|
| 2026-06-30 | $171.00K 10-Q · filed 2026-08-13 | $1.64M 10-Q · filed 2026-08-13 | $2.06M derived: sum of 3 quarters · filed 2026-08-13 | $2.29M derived: sum of 4 quarters · filed 2026-08-13 |
| 2026-03-31 | $1.47M 10-Q · filed 2026-05-04 | $1.88M derived: sum of 2 quarters · filed 2026-05-04 | $2.12M derived: sum of 3 quarters · filed 2026-05-04 | $2.51M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-12-31 | $411.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $648.00K derived: sum of 2 quarters · filed 2026-03-10 | $1.04M derived: sum of 3 quarters · filed 2026-08-13 | $2.28M 10-K · filed 2026-03-10 |
| 2025-09-30 | $237.00K 10-Q · filed 2025-11-10 | $627.00K derived: sum of 2 quarters · filed 2026-08-13 | $1.87M 10-Q · filed 2025-11-10 | $2.35M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-06-30 | $390.00K 10-Q · filed 2026-08-13 | $1.64M 10-Q · filed 2026-08-13 | $2.12M derived: sum of 3 quarters · filed 2026-08-13 | $2.12M derived: sum of 4 quarters · filed 2026-08-13 |
| 2025-03-31 | $1.25M 10-Q · filed 2026-05-04 | $1.73M derived: sum of 2 quarters · filed 2026-05-04 | $1.73M derived: sum of 3 quarters · filed 2026-05-04 | $2.02M derived: sum of 4 quarters · filed 2026-05-04 |
| 2024-12-31 | $482.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-10 | $482.00K derived: sum of 2 quarters · filed 2026-03-10 | $770.00K derived: sum of 3 quarters · filed 2026-03-10 | $1.52M 10-K · filed 2026-03-10 |
| 2024-09-30 | $0.00 10-Q · filed 2025-11-10 | $288.00K derived: sum of 2 quarters · filed 2025-11-10 | $1.04M 10-Q · filed 2025-11-10 | $1.86M derived: sum of 4 quarters · filed 2025-11-10 |
| 2024-06-30 | $288.00K 10-Q · filed 2025-08-12 | $1.04M 10-Q · filed 2025-08-12 | $1.86M derived: sum of 3 quarters · filed 2025-08-12 | $1.86M derived: sum of 4 quarters · filed 2025-08-12 |
| 2024-03-31 | $748.00K 10-Q · filed 2025-05-14 | $1.58M derived: sum of 2 quarters · filed 2025-05-14 | $1.58M derived: sum of 3 quarters · filed 2025-05-14 | $2.30M derived: sum of 4 quarters · filed 2025-05-14 |
| 2023-12-31 | $828.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-27 | $828.00K derived: sum of 2 quarters · filed 2025-03-27 | $1.55M derived: sum of 3 quarters · filed 2025-03-27 | $1.61M 10-K · filed 2025-03-27 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $727.00K derived: sum of 2 quarters · filed 2024-11-07 | $780.00K 10-Q · filed 2024-11-07 | |
| 2023-06-30 | $727.00K 10-Q · filed 2024-08-06 | $780.00K 10-Q · filed 2024-08-06 | ||
| 2023-03-31 | $53.00K 10-Q · filed 2024-05-06 | |||
| 2022-12-31 | $2.17M 10-K · filed 2024-03-13 |